XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Stock award plan - (Tables)
9 Months Ended
Sep. 30, 2025
Stock award plan  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2024

 

8,482,489

$

42.29

 

  

 

  

Granted

 

841,945

$

47.12

 

  

 

  

Exercised

 

(953,414)

$

35.75

 

  

 

  

Forfeited/Cancelled

 

(564,709)

$

53.91

 

  

 

  

Outstanding at September 30, 2025

 

7,806,311

$

42.77

 

5.66

years

$

151,190

Expected to vest at September 30, 2025

 

1,524,459

$

39.30

 

8.53

years

$

33,651

Exercisable at September 30, 2025

 

6,126,727

$

43.71

 

4.86

years

$

114,211

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Nine months ended

    

    

September 30, 2025

    

Risk-free interest rate

 

3.81% - 4.44%

 

Expected volatility

 

55% - 56%

 

Expected term

 

5.5 years

 

Summary of information on the Company's restricted stock

Restricted Stock Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2024

3,527,575

$

33.39

Granted

 

1,615,305

47.16

PSUs with conditions satisfied

 

75,000

28.58

Vested

(1,201,681)

36.79

Forfeited

 

(227,396)

35.27

Unvested at September 30, 2025

 

3,788,803

$

37.98

Schedule of information about Performance-based restricted stock units

Performance-based Restricted Stock Units

    

Performance based

    

Market Conditions

Total

Total PSUs granted for which the performance or market conditions were not yet satisfied at December 31, 2024

175,000

31,250

206,250

PSUs with performance or market conditions satisfied during the period

 

(75,000)

(75,000)

Total PSUs granted for which the performance or market conditions were not yet satisfied at September 30, 2025

 

100,000

31,250

131,250

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2025

    

2024

    

2025

    

2024

Research and development

$

9,133

$

9,416

$

26,827

$

27,810

Selling, general and administrative

 

10,293

 

10,339

 

29,202

 

29,566

Total

$

19,426

$

19,755

$

56,029

$

57,376